未归类页面
来自医学百科
下面显示区间#2,101至#2,150的50条结果。
查看(前50个 | 后50个)(20 | 50 | 100 | 250 | 500)
- Taskirvatinib
- Tazemetostat
- Tecartus
- Tecentriq
- Teclistamab
- Tecvayli
- Telisotuzumab
- Telisotuzumab Vedotin
- Telitacicept
- Temozolomide
- Temsirolimus
- Tenofovir Amibufenamide
- Tepmetko
- Tepotinib
- Tetrabody
- Tfh 细胞
- Th1/Th2 平衡
- Th1/Th2平衡
- Th17
- Th1 细胞
- Thalidomide
- The Best SEnuke XCr Link Building Service964601
- The Journal of Clinical Oncology
- The New England Journal of Medicine
- The Oncologist
- Tibsovo
- Tifcemalimab
- Tirabrutinib
- Tiragolumab
- Tisagenlecleucel
- Tislelizumab
- Tisotumab vedotin-tftv
- Tivantinib
- Tivozanib
- Tocilizumab
- Tofacitinib
- Tolebrutinib
- Tomivosertib
- Top 0.1%
- Top 1%
- Topiroxostat
- Topotecan
- Toripalimab
- Torisel
- Torkinib
- Tositumomab
- Trabectedin
- Transcriptomics
- Trastuzumab
- Trastuzumab deruxtecan